Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/25 16:56 | 4/1/25 | RNA | Health | Drug | Pharmaceutical Preparations | Gallagher Kathleen P. | CA | O | Chief Pr | 4 | S.dm | -803 | 29.71 | 0 | -27 | 51 | D | |||||||||||||||
3/21/25 18:44 | 3/20/25 | RNA | Health | Drug | Pharmaceutical Preparations | Hughes Steven George | CA | O | Chief Me | 2 | S | -410 | 30.34 | 0 | -14 | 82 | D | |||||||||||||||
3/21/25 18:42 | 3/20/25 | RNA | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | 2 | S | -1,277 | 30.45 | 0 | -42 | 337 | D | |||||||||||||||
3/21/25 18:40 | 3/20/25 | RNA | Health | Drug | Pharmaceutical Preparations | Flanagan W. Michael | CA | O | Chief Sc | 3 | S.d | -1,131 | 30.19 | 0 | -37 | 92 | D | |||||||||||||||
3/21/25 18:38 | 3/20/25 | RNA | Health | Drug | Pharmaceutical Preparations | Maclean Michael F | CA | O | CFO | 2 | S | -340 | 30.33 | 0 | -11 | 105 | D | |||||||||||||||
3/21/25 18:36 | 3/20/25 | RNA | Health | Drug | Pharmaceutical Preparations | McCarthy Teresa | CA | O | CHRO | 2 | S | -326 | 30.38 | 0 | -11 | 105 | D | |||||||||||||||
1/23/25 20:17 | 1/21/25 | RNA | Health | Drug | Pharmaceutical Preparations | Levin Arthur A | CA | D | 1 | S | -54 | 28.60 | 0 | -2 | 144 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |